Gujarat Mineral Development Corporation Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 8:58 pm

Competitors of Gujarat Mineral Development Corporation Ltd

All Competitor Stocks of Gujarat Mineral Development Corporation Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:30 pm

Below is a detailed analysis of the quarterly data for Gujarat Mineral Development Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 733.00 Cr.. The value appears to be declining and may need further review. It has decreased from 786.00 Cr. (Mar 2025) to 733.00 Cr., marking a decrease of 53.00 Cr..
• For Expenses, as of Jun 2025, the value is 563.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 593.00 Cr. (Mar 2025) to 563.00 Cr., marking a decrease of 30.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 169.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Mar 2025) to 169.00 Cr., marking a decrease of 25.00 Cr..
• For OPM %, as of Jun 2025, the value is 23.00%. The value appears to be declining and may need further review. It has decreased from 25.00% (Mar 2025) to 23.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 78.00 Cr.. The value appears to be declining and may need further review. It has decreased from 118.00 Cr. (Mar 2025) to 78.00 Cr., marking a decrease of 40.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 22.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 27.00 Cr. (Mar 2025) to 22.00 Cr., marking a decrease of 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 224.00 Cr.. The value appears to be declining and may need further review. It has decreased from 285.00 Cr. (Mar 2025) to 224.00 Cr., marking a decrease of 61.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 27.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 226.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 62.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 5.15. The value appears to be declining and may need further review. It has decreased from 7.11 (Mar 2025) to 5.15, marking a decrease of 1.96.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:14 am

Growth

Last Updated: September 5, 2025, 5:35 am

Balance Sheet

Last Updated: October 10, 2025, 2:08 pm

Below is a detailed analysis of the balance sheet data for Gujarat Mineral Development Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 64.00 Cr..
• For Reserves, as of Mar 2025, the value is 6,348.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,036.00 Cr. (Mar 2024) to 6,348.00 Cr., marking an increase of 312.00 Cr..
• For Borrowings, as of Mar 2025, the value is 126.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 126.00 Cr., marking an increase of 123.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,214.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,266.00 Cr. (Mar 2024) to 1,214.00 Cr., marking a decrease of 52.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,752.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,369.00 Cr. (Mar 2024) to 7,752.00 Cr., marking an increase of 383.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,553.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,551.00 Cr. (Mar 2024) to 1,553.00 Cr., marking an increase of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 741.00 Cr.. The value appears strong and on an upward trend. It has increased from 292.00 Cr. (Mar 2024) to 741.00 Cr., marking an increase of 449.00 Cr..
• For Investments, as of Mar 2025, the value is 484.00 Cr.. The value appears to be declining and may need further review. It has decreased from 566.00 Cr. (Mar 2024) to 484.00 Cr., marking a decrease of 82.00 Cr..
• For Other Assets, as of Mar 2025, the value is 4,974.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,960.00 Cr. (Mar 2024) to 4,974.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,752.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,369.00 Cr. (Mar 2024) to 7,752.00 Cr., marking an increase of 383.00 Cr..

Notably, the Reserves (6,348.00 Cr.) exceed the Borrowings (126.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Gujarat Mineral Development Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 21.57. This value is within the healthy range. It has increased from 19.41 (Mar 24) to 21.57, marking an increase of 2.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 21.57. This value is within the healthy range. It has increased from 19.41 (Mar 24) to 21.57, marking an increase of 2.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 24.60. This value is within the healthy range. It has increased from 21.78 (Mar 24) to 24.60, marking an increase of 2.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 201.63. It has increased from 192.33 (Mar 24) to 201.63, marking an increase of 9.30.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 201.63. It has increased from 192.33 (Mar 24) to 201.63, marking an increase of 9.30.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 89.65. It has increased from 77.45 (Mar 24) to 89.65, marking an increase of 12.20.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 31.24. This value is within the healthy range. It has increased from 28.19 (Mar 24) to 31.24, marking an increase of 3.05.
• For PBIT / Share (Rs.), as of Mar 25, the value is 28.24. This value is within the healthy range. It has increased from 25.71 (Mar 24) to 28.24, marking an increase of 2.53.
• For PBT / Share (Rs.), as of Mar 25, the value is 28.17. This value is within the healthy range. It has increased from 25.62 (Mar 24) to 28.17, marking an increase of 2.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 21.60. This value is within the healthy range. It has increased from 19.31 (Mar 24) to 21.60, marking an increase of 2.29.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 21.57. This value is within the healthy range. It has increased from 19.41 (Mar 24) to 21.57, marking an increase of 2.16.
• For PBDIT Margin (%), as of Mar 25, the value is 34.84. This value is within the healthy range. It has decreased from 36.39 (Mar 24) to 34.84, marking a decrease of 1.55.
• For PBIT Margin (%), as of Mar 25, the value is 31.49. This value exceeds the healthy maximum of 20. It has decreased from 33.19 (Mar 24) to 31.49, marking a decrease of 1.70.
• For PBT Margin (%), as of Mar 25, the value is 31.42. This value is within the healthy range. It has decreased from 33.08 (Mar 24) to 31.42, marking a decrease of 1.66.
• For Net Profit Margin (%), as of Mar 25, the value is 24.09. This value exceeds the healthy maximum of 10. It has decreased from 24.92 (Mar 24) to 24.09, marking a decrease of 0.83.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 24.05. This value exceeds the healthy maximum of 20. It has decreased from 25.06 (Mar 24) to 24.05, marking a decrease of 1.01.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.69. This value is below the healthy minimum of 15. It has increased from 10.09 (Mar 24) to 10.69, marking an increase of 0.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.43. This value is within the healthy range. It has increased from 11.99 (Mar 24) to 12.43, marking an increase of 0.44.
• For Return On Assets (%), as of Mar 25, the value is 8.84. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 8.84, marking an increase of 0.47.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.37. It has increased from 0.34 (Mar 24) to 0.37, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 4.72. This value exceeds the healthy maximum of 3. It has decreased from 4.74 (Mar 24) to 4.72, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 2. There is no change compared to the previous period (Mar 24) which recorded 4.54.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 58.98 (Mar 24) to 0.00, marking a decrease of 58.98.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 52.31 (Mar 24) to 0.00, marking a decrease of 52.31.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 41.02 (Mar 24) to 0.00, marking a decrease of 41.02.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 47.69 (Mar 24) to 0.00, marking a decrease of 47.69.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 455.65. This value is within the healthy range. It has increased from 306.58 (Mar 24) to 455.65, marking an increase of 149.07.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 316.10. This value is within the healthy range. It has increased from 210.99 (Mar 24) to 316.10, marking an increase of 105.11.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,978.23. It has decreased from 10,425.63 (Mar 24) to 7,978.23, marking a decrease of 2,447.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.80. This value is within the healthy range. It has decreased from 4.23 (Mar 24) to 2.80, marking a decrease of 1.43.
• For EV / EBITDA (X), as of Mar 25, the value is 8.03. This value is within the healthy range. It has decreased from 11.63 (Mar 24) to 8.03, marking a decrease of 3.60.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.96. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 2.96, marking a decrease of 1.48.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 41.01 (Mar 24) to 0.00, marking a decrease of 41.01.
• For Price / BV (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has decreased from 1.79 (Mar 24) to 1.32, marking a decrease of 0.47.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.96. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 2.96, marking a decrease of 1.48.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness